Hims & Hers pulls copycat weight-loss pill after threats of legal action
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.
In reversal, Trump backs Nexstar’s proposed acquisition of Tegna
President Donald Trump on Saturday expressed support for Nexstar’s bid for Tegna, which would significantly expand the network’s reach.
NFL plans to have discussions with partners outside of core media for live games, media chief says
NFL plans to look outside traditional media for potential partners for live games, NFL Media chief Hans Schroeder said.
Nearly a thousand Google workers sign letter urging company to divest from ICE, CBP
Hundreds of Google workers signed an open letter urging the company to cut its ties with ICE and CBP after rising violence.
Gen Z is nostalgic for 2016 amid economic unease. Mall brands like Abercrombie & Fitch may see a revival
Economic anxiety is pushing Gen Z toward familiar mid-2010s aesthetics, a shift that could translate into renewed demand for legacy mall retailers.
These stocks are deeply oversold after this week’s market turmoil — and due for a bounce
CNBC Pro screened for the most oversold names on Wall Street after a dizzying week.
Five stocks with more upside based on their latest earnings, according to Bank of America
Bank of America named five stocks this week that have plenty more room to run.
Fivespan brings amicable activism to Appian in a bid to lift the share price and build value
The activist firm prefers to take a “behind the scenes” approach when it works with a portfolio company.
Trump administration equity stakes pose risks to U.S. companies and markets
The Trump administration’s growing portfolio of direct investments is unprecedented outside an economic crisis or wartime.
Buffett Watch: Berkshire Hathaway outperforms this week as tech stocks sink
Berkshire Hathaway’s stock outperformed the benchmark S&P 500 stock index this week as investors sought safety from tech selling.